Recent updates on animal models for understanding the etiopathogenesis of polycystic ovarian syndrome

被引:49
|
作者
Corrie, Leander [1 ]
Gulati, Monica [1 ]
Singh, Sachin Kumar [1 ]
Kapoor, Bhupinder [1 ]
Khursheed, Rubiya [1 ]
Awasthi, Ankit [1 ]
Vishwas, Sukriti [1 ]
Chellappan, Dinesh Kumar [2 ]
Gupta, Gaurav [3 ]
Jha, Niraj Kumar [4 ]
Anand, Krishnan [5 ]
Dua, Kamal [6 ]
机构
[1] Lovely Profess Univ, Sch Pharmaceut Sci, Phagwara 144411, Punjab, India
[2] Int Med Univ, Sch Pharm, Dept Life Sci, Kuala Lumpur 57000, Malaysia
[3] Suresh Gyan Vihar Univ, Sch Pharm, Mahal Rd, Jaipur, Rajasthan, India
[4] Sharda Univ, Sch Engn & Technol SET, Dept Biotechnol, Greater Noida 201310, Uttar Pradesh, India
[5] Univ Free State, Fac Hlth Sci, Sch Pathol, Dept Chem Pathol,Natl Hlth Lab Serv, Bloemfontein, South Africa
[6] Univ Technol Sydney, Grad Sch Hlth, Discipline Pharm, Ultimo, Australia
关键词
Polycystic ovarian syndrome; Luteinizing hormone; Dehydroepiandrosterone model; Dihydrotestosterone model; Letrozole; SEX STEROID-RECEPTORS; ESTRADIOL VALERATE; RAT MODEL; INSULIN-RESISTANCE; FOLLICULAR DEVELOPMENT; LUTEINIZING-HORMONE; SIGNALING PATHWAY; OXIDATIVE STRESS; GENE-EXPRESSION; CYSTIC OVARIES;
D O I
10.1016/j.lfs.2021.119753
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Polycystic ovarian syndrome (PCOS) is the primary cause of female infertility affecting several women worldwide. Changes in hormonal functions such as hyperandrogenism are considered a significant factor in developing PCOS in women. In addition, many molecular pathways are involved in the pathogenesis of PCOS in women. To have better insights about PCOS, it is data from clinical studies carried on women suffering from PCOS should be collected. However, this approach has several implications, including ethical considerations, cost involved and availability of subject. Moreover, during the early drug development process, it is always advisable to use nonhuman models mimicking human physiology as they are less expensive, readily available, have a shorter gestation period and less risk involved. Many animal models have been reported that resemble the PCOS pathways in human subjects. However, the models developed on rats and mice are more preferred over other rodent/non-rodent models due to their closer resemblance with human PCOS development mechanism. The most extensively reported PCOS models for rats and mice include those induced by using testosterone, letrozole and estradiol valerate. As the pathophysiology of PCOS is complex, none of the explored models completely surrogates the PCOS related conditions occurring in women. Hence, there is a need to develop an animal model that can resemble the pathophysiology of PCOS in women. The review focuses on various animal models explored to understand the pathophysiology of PCOS. The article also highlights some environmental and food-related models that have been used to induce PCOS.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Polycystic Ovarian Syndrome
    Shrivastava, Sneha
    Conigliaro, Rosemarie L.
    MEDICAL CLINICS OF NORTH AMERICA, 2023, 107 (02) : 227 - 234
  • [22] Mechanisms of the follicular wall thickening in polycystic ovarian syndrome models
    Santoso, B.
    Prabowo, P.
    Sucipto
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 : 129 - 129
  • [23] Updated experimental cellular models to study polycystic ovarian syndrome
    Sudhakaran, Gokul
    Babu, Sarvesh Ramesh
    Mahendra, Hridai
    Arockiaraj, Jesu
    LIFE SCIENCES, 2023, 322
  • [24] Understanding polycystic ovarian syndrome pathogenesis: An updated of its genetic aspects
    Calogero, A. E.
    Calabro, V.
    Catanuso, M.
    Condorelli, R. A.
    La Vignera, S.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2011, 34 (08): : 630 - 644
  • [25] Understanding polycystic ovarian syndrome pathogenesis: An updated of its genetic aspects
    A. E. Calogero
    V. Calabrò
    M. Catanuso
    R. A. Condorelli
    S. La Vignera
    Journal of Endocrinological Investigation, 2011, 34 : 630 - 644
  • [26] A Complete Overview of the Polycystic Ovarian Syndrome with Recent Advancement in Clinical Trial
    Mukherjee, Swarupananda
    Rai, Deepti
    Ghoshal, Debjit
    Chakraborty, Tania
    Karati, Dipanjan
    CURRENT WOMENS HEALTH REVIEWS, 2025, 21 (02)
  • [27] Ovarian stimulation in polycystic ovarian syndrome
    Or, Yuval
    Shoham, Zeev
    INTERNATIONAL SURGERY, 2006, 91 (05) : S25 - S30
  • [28] Optimization of assisted reproductive technology outcomes in patients with polycystic ovarian syndrome: updates and unanswered questions
    Fitz, Victoria W.
    Mahalingaiah, Shruthi
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2022, 29 (06) : 547 - 553
  • [29] Recent Updates in Understanding NSAID Hypersensitivity
    Minaldi, Ellen
    Cahill, Katherine
    CURRENT ALLERGY AND ASTHMA REPORTS, 2023, 23 (03) : 181 - 188
  • [30] Recent Updates in Understanding NSAID Hypersensitivity
    Ellen Minaldi
    Katherine Cahill
    Current Allergy and Asthma Reports, 2023, 23 : 181 - 188